|
| |
|
 |
|
|
| [DISPLAY PATENT] |
| |
| |
|
|
| Application no. and date | 15728491.0 (espacenet) (Federated) (European Patent Register), 20150608 | | Patent/reg. no. and date | DK/EP 3151851, 20211201 | | Publication date | 20170412 | | Priority no. and date | GB 201410116, 20140606 | | EP pub. no. and date |
EP 3151851 20170412 | | Effective date | | | Applicant/owner | Volution Immuno Pharmaceuticals SA, Place Des Eaux Vives 6,
3461-1211 Geneve 3, CH | | Applicant ref. no. | P79077DK01 | | Inventor | WESTON-DAVIES, Wynne H, Rosebank
Salperton
Cheltenham GL54 4EF, GB | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | | Opponent | | | IPC Class | A61K 38/17 (2006.01) , A61P 37/00 (2006.01) | | Title | ORNITHODOROS-MOUBATA-KOMPLEMENT-INHIBITOR TIL ANVENDELSE I BEHANDLINGEN AF KOMPLEMENT-MEDIEREDE SYGDOMME HOS PATIENTER MED C5-POLYMORFISME | | Int. application no. | EP2015062742 | | Int. publication no. | WO2015185760 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
|
|
|
|
